YTHDC2 and ischemic stroke: Collectively, our findings identified a METTL3/AU020206/YTHDC2/SLC7A11 axis that curbs ferroptotic injury after cerebral I/R and highlight epitranscriptomic modulation of lncRNA stability as a promising therapeutic avenue for ischaemic stroke.